中文版
Signaling Pathways
Laduviglusib
Catalog No. :
CL1006
Product Name :
Laduviglusib
CAS No. :
252917-06-9
Synonyms :
CHIR-99021 (CT99021)
Chemical Name :
Molecular Formula :
C22H18Cl2N8
Molecular Weight :
465.34
Molecular Structure :
Appearance :
Off-white to light brown powder
Specification :
99+%
Application :
Registration :
Storage Condition :

Laduviglusib (CHIR-99021, CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively. CHIR99201 does not exhibit cross-reactivity against cyclin-dependent kinases (CDKs) and shows a 350-fold selectivity toward GSK-3β compared to CDKs. CHIR99021 functions as a Wnt/β-catenin activator and induces autophagy.


Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.

Request A Quote
Your Name(required)
Email(required)
Product Name(required)
Country or Region(required)
Organization Name(required)
Messages(required)
Captcha(required)
Sending...